Trial · NCT07886216
Effect of Methotrexate on Blood Loss During Laparoscopic Management of CS Scar Pregnancy
NCT07886216, Not yet recruiting, Assiut University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Methotrexate on Blood Loss During Laparoscopic Management of CS Scar Pregnancy. Trials, record NCT07886216. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07886216
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Methotrexate on Blood Loss During Laparoscopic Management of CS Scar Pregnancy
- NCT number
- NCT07886216
- Status
- Not yet recruiting
- Enrollment
- 42 participants, estimated
- Lead sponsor
- Assiut University
- Conditions
- Cesarean Scar Pregnancy
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intraoperative blood loss | During laparoscopic surgery, from the beginning of the procedure until completion of surgical hemostasis. | Estimated blood loss during laparoscopic resection and repair of cesarean scar pregnancy, measured in milliliters using the volume collected in the suction container after subtraction of irrigation fluids, together with assessment of blood absorbed by surgical gauzes. |
| Secondary | Operative time | From insertion of the first trocar to removal of the last trocar. | Duration of the laparoscopic surgical procedure, measured in minutes. |
| Secondary | Perioperative hemoglobin change | Preoperative and 6 hours post operative. | Change in hemoglobin concentration between the preoperative and postoperative measurements. |
| Secondary | Blood transfusion requirement | From start of surgery till hospital discharge. | Need for blood transfusion |
| Secondary | Additional hemostatic procedures | From insertion of the first trocar to removal of the last trocar. | Requirement for additional procedures to control intraoperative bleeding, including additional hemostatic sutures, bilateral uterine artery ligation, or other hemostatic procedures. |
| Secondary | Intraoperative complications | From insertion of the first trocar to removal of the last trocar. | Occurrence of intraoperative complications including bladder injury, ureteric injury, bowel injury, major vascular injury, or conversion to laparotomy. |
| Secondary | Length of post operative hospital stay | From completion of surgery until hospital discharge. | Duration of hospitalization measured from surgery until discharge. |
| Secondary | Postoperative complications | From hospital discharge to 1 week after discharge. | Occurrence of postoperative complications during follow-up after laparoscopic surgery. |
| Secondary | Cesarean scar healing | 3 months after surgery | Cesarean scar healing assessed by transvaginal ultrasonography, including residual myometrial thickness, scar integrity, and presence of a niche defect. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07886216
GET https://conductscience.org/api/trials/v1/NCT07886216/registered